These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of non-small cell lung cancer: advanced (metastatic) disease. Guidelines of clinical practice made by the European Lung Cancer Working Party]. European Lung Cancer Working Party Rev Med Brux; 2007; 28(6):495-511. PubMed ID: 18265809 [TBL] [Abstract][Full Text] [Related]
3. [Management of unresectable non-metastatic non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party]. Paesmans M; Rev Med Brux; 2014; 35(3):140-4. PubMed ID: 25102580 [TBL] [Abstract][Full Text] [Related]
4. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Okawara G; Rusthoven J; Newman T; Findlay B; Evans W Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750 [TBL] [Abstract][Full Text] [Related]
5. [Evidence-based practice guideline for unresectable advanced lung cancer in 2003]. Fukuoka M; Kurata T; Yamamoto N Nihon Geka Gakkai Zasshi; 2004 Jul; 105(7):412-6. PubMed ID: 15303441 [TBL] [Abstract][Full Text] [Related]
6. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy. Socinski MA Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966 [TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study. Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N J BUON; 2007; 12(1):33-9. PubMed ID: 17436399 [TBL] [Abstract][Full Text] [Related]
8. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party]. Sculier JP; Rev Med Brux; 2014; 35(3):134-9. PubMed ID: 25102579 [TBL] [Abstract][Full Text] [Related]
9. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?]. Baumann M Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558 [No Abstract] [Full Text] [Related]
10. [Management of extensive disease small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party]. Grigoriu B; Meert AP; Rev Med Brux; 2014; 35(3):164-8. PubMed ID: 25102583 [TBL] [Abstract][Full Text] [Related]
11. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance. Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170 [TBL] [Abstract][Full Text] [Related]
12. First- and second-line therapy for advanced nonsmall cell lung cancer. Sculier JP; Moro-Sibilot D Eur Respir J; 2009 Apr; 33(4):915-30. PubMed ID: 19336594 [TBL] [Abstract][Full Text] [Related]
13. Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer. van Zandwijk N; Dalesio O Semin Oncol; 1994 Jun; 21(3 Suppl 6):66-71. PubMed ID: 8052876 [TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Jiang J; Liang X; Zhou X; Huang R; Chu Z Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133 [TBL] [Abstract][Full Text] [Related]